Penserra Capital Management LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2021$75,000
+5.6%
4,205
+1.3%
0.00%
+100.0%
Q2 2021$71,000
-13.4%
4,150
+0.7%
0.00%
-50.0%
Q1 2021$82,000
+17.1%
4,120
-0.6%
0.00%0.0%
Q4 2020$70,000
+180.0%
4,145
+171.3%
0.00%
+100.0%
Q3 2020$25,000
-51.0%
1,528
+81.0%
0.00%
-66.7%
Q3 2018$51,000
-95.6%
844
-96.4%
0.00%
-95.9%
Q2 2018$1,153,00023,6310.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders